1.
C Langer, E Lengfelder, J Thiele, HM Kvasnicka, HL Pahl, H Beneke, S Schauer, H Gisslinger, M Griesshammer. Pegylated interferon for the treatment of high risk essential thrombocythemia: results of a phase II study. haematol [Internet]. 2005Jan.1 [cited 2022May22];90(10):1333-8. Available from: https://haematologica.org/article/view/3689